Exercise during Chemotherapy for Ovarian Cancer (ECHO): study design features and outcomes of a Cancer Australia and Cancer Council Australia funded randomized, controlled trial [Conference Abstract]
2014
Ovarian cancer is the most common cause of gynaecological cancer death, with an
overall 5-year relative survival of 43%. Impaired physical wellbeing and overall
quality of life (QoL) represent major concerns for women during and following
ovarian cancer treatment, predict survival and are amenable to change through
interventions. Exercise, now considered an important part of overall management of a
number of cancers, improves short-term outcomes (e.g., function, fatigue, QoL)
during chemotherapy...
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI